Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

Targeted therapeutics based on engineered proteins for tyrosine kinases receptors, including IGF-IR

US Patent 11149077 · Granted Oct 19, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Histidyl-tRNA synthetase-Fc conjugates and therapeutics using the same2025
Compositions and methods for evaluating genomic alterations2025
Therapeutic and diagnostic methods for cancer2025
Nucleic acids encoding modified FGF-21 polypeptides, vectors and cells containin2025
PD-L1 binding polypeptides for imaging2025
PD-L1 binding polypeptides for imaging2025
Fibronectin based scaffold domain proteins that bind PCSK92024
Compositions and methods for treating lung inflammation2023
Methods of treating cancer2023
Therapeutic and diagnostic methods for cancer2023
Fibronectin binding domains with reduced immunogenicity2022
PET imaging with PD-L1 binding polypeptides2022